Panel Discussion: Realising The Impact of mRNA Medicine Perception on Public Health
Time: 9:30 am
day: Day Two AM
• Understanding the complexity of the regulatory and scientific classification of innovative RNA products
• Gaining perspective on the intersection of public health and regulatory landscape from drug discovery to patient access
• What is the value for patients of more granularity in medicine classification?
• How can we increase public health benefits of mRNA medicines by improving the understanding of this new technology?